advertisement

Companies

Global drug firms sign deal to cut cost of cancer medicines in Kenya

David Makumi of Kenya Network of Cancer Organisations. FILE PHOTO | NMG
David Makumi of Kenya Network of Cancer Organisations. FILE PHOTO | NMG 

Two global drug manufacturers, Pfizer and Cipla, have signed a deal that will see Kenyans buy a range of up to 16 cancer drugs at half the market price.

The partnership is backed by the American Cancer Society (ACS) and Clinton Health Access Initiative (CHAI).

The deal will see an increase in access to life-saving cancer treatment including chemotherapies in five other African countries; Ethiopia, Nigeria Uganda, Rwanda and Tanzania.

Pfizer will provide 11 branded cancer medicines namely; Carboplatin, Cisplatin, Docetaxel, Doxorubicin, Epirubicin, Fluorouracil, Gemcitabine, Leucovorin, Methotrexate, Oxaliplatin, and Paclitaxel.

advertisement